Home potential
 

Keywords :   


Tag: potential

NFU: Currency Manipulation Again Being Used by Potential TPP Partner to Gain Unfair Advantage Over U.S. Farmers and Ranchers

2015-08-20 17:45:29| National Farmers Union

FOR IMMEDIATE RELEASE August 20, 2015 Contact: Andrew Jerome, 202-314-3106 ajerome@nfudc.org WASHINGTON (August 20, 2015) National Farmers Union (NFU) President Roger Johnson today again urged the administration to ensure that the final Trans-Pacific Partnership (TPP) agreement include strong language against currency manipulation, which has been used recently by two of our trading partners –

Tags: us partner potential advantage

 

Visa: A Potential Long-Term Growth Investment Based On Philip Fisher's Criteria

2015-08-13 22:59:21| Steel - Topix.net

Legendary investor Philip Fisher once presented 15 points that a company must pass in order for it to be justified as a strong investment. Philip Fisher's long-term track record is truly magnificent, and any stock that passes his criteria should be seriously considered for an investment.

Tags: based potential growth visa

 
 

Brazil's Gerdau considers potential asset sales

2015-08-13 06:43:51| Steel - Topix.net

Aug 12 Brazilian steelmaker Gerdau SA is re-evaluating the profitability of its joint ventures for potential future asset sales, Chief Executive Andre Gerdau Johannpeter told analysts in a conference call on Wednesday.

Tags: sales potential asset considers

 

ILL team uses neutron scattering to elucidate structure and dynamics of superionic conductor Li4C60; potential for batteries and fuel cells

2015-08-05 17:56:10| Green Car Congress

Tags: team potential structure cells

 

Pfizer And Synthon Enter Into U.S. Commercialization Agreement For Potential Generic Treatment Of Multiple Sclerosis

2015-08-05 07:09:59| drugdiscoveryonline Home Page

Pfizer Inc. and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, recently announced they have entered into an agreement whereby Pfizer has acquired the exclusive commercialization rights in the United States to glatiramer acetate, a potential generic version of the originator medicine Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS)

Tags: of enter agreement multiple

 

Sites : [360] [361] [362] [363] [364] [365] [366] [367] [368] [369] [370] [371] [372] [373] [374] [375] [376] [377] [378] [379] next »